Increasing Investments in Biopharmaceutical R&D Fueling Market Growth
The global monoclonal antibodies market is set for remarkable growth, as targeted biologic therapies increasingly dominate treatment protocols in oncology, autoimmune disorders, infectious diseases and beyond. In 2024 the market was estimated at approximately USD 263.22 billion, and it is projected to rise to around USD 719.81 billion by 2032, reflecting a compound annual...
0 Commentaires 0 Parts 15 Vue 0 Aperçu